Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Ageing Research Reviews

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.arr.2015.10.002PMID 26474742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds.

  2016cited by this paper
• NF-κB activation impairs somatic cell reprogramming in ageing

  2015cited by this paper
• Pluripotent stem cell-based models of spinal muscular atrophy.

  2015cited by this paper
• Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs

  2015cited by this paper
• Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue

  2014cited by this paper
• Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes

  2014cited by this paper
• Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models

  2014cited by this paper
• Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1

  2014cited by this paper
• Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4.

  2014cited by this paper
• Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts

  2014cited by this paper
• iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1

  2014cited by this paper
• Chemical Inhibition of NAT10 Corrects Defects of Laminopathic Cells

  2014cited by this paper
• Progeria: a paradigm for translational medicine.

  2014cited by this paper
• Dysregulated interactions between lamin A and SUN1 induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric laminopathies

  2014influential reference
• Targeted gene therapy and cell reprogramming in Fanconi anemia

  2014cited by this paper
• Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells

  2014cited by this paper
• Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in Patients With Hutchinson‐Gilford Progeria Syndrome

  2014cited by this paper
• SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

  2014cited by this paper
• Identification of small molecules for human hepatocyte expansion and iPS differentiation

  2013cited by this paper
• Human iPSC-based modeling of late-onset disease via progerin-induced aging.

  2013cited by this paper
• Phenotypic Screening with Human iPS Cell–Derived Cardiomyocytes

  2013cited by this paper
• A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1.

  2013cited by this paper
• Identification and Rescue of -Synuclein Toxicity in Parkinson Patient-Derived Neurons

  2013cited by this paper
• mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1

  2013cited by this paper
• A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.

  2013cited by this paper
• Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.

  2013cited by this paper
• Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation

  2013cited by this paper
• Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons

  2013cited by this paper
• Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome

  2012cited by this paper
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• iPSC technology to study human aging and aging-related disorders.

  2012cited by this paper
• Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells

  2012cited by this paper
• Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

  2012cited by this paper
• Overcoming reprogramming resistance of Fanconi anemia cells.

  2012cited by this paper
• Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy

  2012cited by this paper
• Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies.

  2012influential reference
• Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA.

  2012cited by this paper
• Progressive degeneration of human neural stem cells caused by pathogenic LRRK2

  2012cited by this paper
• Nuclear lamina at the crossroads of the cytoplasm and nucleus.

  2012cited by this paper
• Human pluripotent stem cells for disease modelling and drug screening.

  2012cited by this paper
• Modeling familial Alzheimer's disease with induced pluripotent stem cells.

  2011cited by this paper
• Recapitulation of premature aging with iPSCs from Hutchinson-Gilford progeria syndrome

  2011cited by this paper
• A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.

  2011cited by this paper
• Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy.

  2011cited by this paper
• Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts.

  2011cited by this paper
• Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells

  2011cited by this paper
• In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.

  2011cited by this paper
• Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging

  2011cited by this paper
• High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules.

  2010cited by this paper
• Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence

  2010cited by this paper
• Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

  2009cited by this paper
• A small molecule primes embryonic stem cells for differentiation.

  2009cited by this paper
• Induced pluripotent stem cells from a spinal muscular atrophy patient

  2009cited by this paper
• Activating the synthesis of progerin, the mutant prelamin A in Hutchinson–Gilford progeria syndrome, with antisense oligonucleotides

  2009cited by this paper
• Telomere length in Hutchinson-Gilford progeria syndrome.

  2009cited by this paper
• The central role of chromatin maintenance in aging

  2009cited by this paper
• Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells

  2009cited by this paper
• Phenotype and course of Hutchinson-Gilford progeria syndrome.

  2008influential reference
• Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A.

  2008cited by this paper
• Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging

  2008cited by this paper
• A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells.

  2008cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin

  2007cited by this paper
• A lamin A protein isoform overexpressed in Hutchinson–Gilford progeria syndrome interferes with mitosis in progeria and normal cells

  2007cited by this paper
• The laminopathies: the functional architecture of the nucleus and its contribution to disease.

  2006cited by this paper
• A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria

  2006cited by this paper
• Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.

  2006cited by this paper
• Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson–Gilford progeria syndrome

  2006cited by this paper
• Quantitative analysis of localization and nuclear aggregate formation induced by GFP‐lamin A mutant proteins in living HeLa cells

  2006cited by this paper
• Genomic instability in laminopathy-based premature aging

  2005cited by this paper
• Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.

  2005cited by this paper
• Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome

  2005influential reference
• Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson–Gilford progeria syndrome

  2004influential reference
• Lamin A Truncation in Hutchinson-Gilford Progeria

  2003cited by this paper
• Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome

  2003cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Immortalization of Werner syndrome and progeria fibroblasts.

  1991cited by this paper
• Congenital Absence of Hair and Mammary Glands with Atrophic Condition of the Skin and its Appendages, in a Boy whose Mother had been almost wholly Bald from Alopecia Areata from the age of Six.

  year unknowncited by this paper

• NAT10-mediated ac4C modification of Lipin1 mRNA contributes to the pathogenesis of PWMI

  2025cites this paper
• Vascular organoid model of Hutchinson-Gilford progeria syndrome uncovers repression of the SRF pathway in premature aging.

  2025cites this paper
• Mesenchymal Stem Cell Therapy for Hutchinson–Gilford Progeria: Improvements in Arterial Stiffness and Bone Mineral Density in a Single Case

  2025cites this paper
• Application of mesenchymal stem cells for anti-senescence and clinical challenges

  2023cites this paper
• Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification

  2022cites this paper
• Elevation of N-acetyltransferase 10 in hippocampal neurons mediates depression- and anxiety-like behaviors.

  2022cites this paper
• Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic LMNA Mutations

  2018cites this paper
• Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome

  2018cites this paper
• Fighting against Skin Aging

  2018cites this paper
• Drug discovery and development for rare genetic disorders

  2017cites this paper
• Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells

  2016cites this paper
• Hallmarks of progeroid syndromes : lessons from mice and reprogrammed cells

  2016cites this paper
• A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells

  2016cites this paper
• Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells

  2016cites this paper
• Vitamin C alleviates aging defects in a stem cell model for Werner syndrome

  2016cites this paper